10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America

5. Edwards Lifesciences Corp (NYSE:EW)

Number of Hedge Fund Investors: 47

Medical technology company Edwards Lifesciences Corp (NYSE:EW) is one of the best of breed stocks to buy for the third quarter according to Bank of America. Edwards Lifesciences Corp (NYSE:EW)  is one of the leaders in the transcatheter heart valve replacement. During the first quarter, its transcatheter aortic valve replacement (TAVR) revenue rose 6%, while transcatheter mitral and tricuspid therapies (TMTT) sales jumped a whopping 75%.

 Earlier this month, Goldman Sachs added the stock to its Conviction list, saying Edwards Lifesciences Corp (NYSE:EW) is a pioneer in the transcatheter aortic valve replacement (TAVR). Goldman expects Edward Life Sciences Inc (NYSE:EW) to be successful in its product cycle transition.

Carillon Scout Mid Cap Fund stated the following regarding Edwards Lifesciences Corporation (NYSE:EW) in its first quarter 2024 investor letter:

“Edwards Lifesciences Corporation (NYSE:EW) was the third-largest contributor. Edwards designs, manufactures and markets products such as heart valves to treat cardiovascular disease. The stock performed well after a competitor delayed, and potentially cancelled, its entry into the aortic heart valve replacement market. Edwards also received approval from the U.S. Food and Drug Administration for its tricuspid valve replacement product much sooner than expected. We continue to find the company’s market position and growth opportunities attractive.”